4.91
-0.11(-2.19%)
Currency In USD
| Previous Close | 5.02 |
| Open | 5.01 |
| Day High | 5.01 |
| Day Low | 4.91 |
| 52-Week High | 19.49 |
| 52-Week Low | 4.16 |
| Volume | 26,716 |
| Average Volume | 72,951 |
| Market Cap | 37.24M |
| PE | -3.07 |
| EPS | -1.6 |
| Moving Average 50 Days | 5.05 |
| Moving Average 200 Days | 8.34 |
| Change | -0.11 |
If you invested $1000 in electroCore, Inc. (ECOR) since IPO date, it would be worth $16.49 as of October 19, 2025 at a share price of $4.91. Whereas If you bought $1000 worth of electroCore, Inc. (ECOR) shares 5 years ago, it would be worth $189.21 as of October 19, 2025 at a share price of $4.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
GlobeNewswire Inc.
Sep 30, 2025 12:00 PM GMT
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers in Neurology demonstrating th
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
GlobeNewswire Inc.
Sep 29, 2025 12:00 PM GMT
ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a long-term reimbursement poli
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
ROCKAWAY, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its Truvaga™ Plus handheld vagus nerve stimulation (nVNS) device has been name